Robert Fürst

4.9k total citations · 1 hit paper
119 papers, 3.7k citations indexed

About

Robert Fürst is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Robert Fürst has authored 119 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 20 papers in Epidemiology and 17 papers in Organic Chemistry. Recurrent topics in Robert Fürst's work include HIV, Drug Use, Sexual Risk (10 papers), Substance Abuse Treatment and Outcomes (8 papers) and Cancer-related Molecular Pathways (7 papers). Robert Fürst is often cited by papers focused on HIV, Drug Use, Sexual Risk (10 papers), Substance Abuse Treatment and Outcomes (8 papers) and Cancer-related Molecular Pathways (7 papers). Robert Fürst collaborates with scholars based in Germany, United States and Austria. Robert Fürst's co-authors include Angelika M. Vollmar, Ilse Zündorf, Stefan Zahler, Alexandra K. Kiemer, Oliver Kayser, Thomas Efferth, Michael Heinrich, Giovanni Appendino, Angelo A. Izzo and John M. Pezzuto and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Robert Fürst

116 papers receiving 3.6k citations

Hit Papers

Best practice in research – Overcoming common challenges ... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Best practice in research – Overcoming common challenges in phytopharmacological research
    2019 369 citations Robert Fürst et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Fürst Germany 32 1.4k 570 393 380 352 119 3.7k
Xiaofei Chen China 36 2.2k 1.6× 259 0.5× 305 0.8× 413 1.1× 425 1.2× 203 4.2k
Bikash Medhi India 37 1.4k 1.0× 335 0.6× 470 1.2× 280 0.7× 256 0.7× 254 5.3k
Zhihao Liu China 35 1.6k 1.2× 570 1.0× 306 0.8× 632 1.7× 785 2.2× 239 4.1k
Srinivasa Reddy Bonam United States 41 2.1k 1.5× 574 1.0× 580 1.5× 216 0.6× 592 1.7× 140 5.5k
Hong Ding China 32 1.7k 1.2× 319 0.6× 261 0.7× 271 0.7× 205 0.6× 123 3.5k
Rongsheng Tong China 32 1.8k 1.3× 216 0.4× 275 0.7× 262 0.7× 619 1.8× 116 4.1k
Junko Watanabe Japan 29 1.9k 1.4× 372 0.7× 367 0.9× 612 1.6× 400 1.1× 141 4.6k
Fei Ye China 27 1.5k 1.1× 344 0.6× 263 0.7× 244 0.6× 635 1.8× 104 4.8k
Muhammad Afzal Saudi Arabia 35 1.3k 0.9× 204 0.4× 370 0.9× 372 1.0× 205 0.6× 305 4.3k
Yun Jung Lee South Korea 34 1.5k 1.1× 422 0.7× 342 0.9× 352 0.9× 311 0.9× 245 4.0k

Countries citing papers authored by Robert Fürst

Since Specialization
Citations

This map shows the geographic impact of Robert Fürst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Fürst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Fürst more than expected).

Fields of papers citing papers by Robert Fürst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Fürst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Fürst. The network helps show where Robert Fürst may publish in the future.

Co-authorship network of co-authors of Robert Fürst

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Fürst. A scholar is included among the top collaborators of Robert Fürst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Fürst. Robert Fürst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wolf, Anne, Dominik C. Fuhrmann, Dominique Thomas, et al.. (2025). Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activity. Cellular and Molecular Life Sciences. 82(1). 85–85. 1 indexed citations
3.
Erkoc, Pelin, Susanne Schiffmann, Thomas Ulshöfer, et al.. (2024). Determining the pharmacological potential and biological role of linear pseudoscorpion toxins via functional profiling. iScience. 27(7). 110209–110209. 6 indexed citations
4.
Mačinković, Igor, Andreas Weigert, Matthias P. Fabritius, et al.. (2023). The Microtubule-Targeting Agent Pretubulysin Impairs the Inflammatory Response in Endothelial Cells by a JNK-Dependent Deregulation of the Histone Acetyltransferase Brd4. Cells. 12(16). 2112–2112. 3 indexed citations
5.
6.
Damm, Maik, Pelin Erkoc, Susanne Schiffmann, et al.. (2023). Venomics of the milos viper (Macrovipera schweizeri) unveils patterns of venom composition and exochemistry across blunt-nosed viper venoms. Frontiers in Molecular Biosciences. 10. 1254058–1254058. 13 indexed citations
7.
Tertel, Tobias, Christoph Lipps, James Adjaye, et al.. (2022). Detailed Characterization of Small Extracellular Vesicles from Different Cell Types Based on Tetraspanin Composition by ExoView R100 Platform. International Journal of Molecular Sciences. 23(15). 8544–8544. 41 indexed citations
8.
Breunig, Peter, Lilia Weizel, Jasmin K. Hefendehl, et al.. (2022). Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells. ACS Medicinal Chemistry Letters. 13(7). 1062–1067. 2 indexed citations
9.
Fürst, Robert, et al.. (2022). Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells. Frontiers in Pharmacology. 13. 844767–844767. 31 indexed citations
10.
Michalakis, Stylianos, et al.. (2022). The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2- and TAZ-signaling. Biomedicine & Pharmacotherapy. 152. 113174–113174. 4 indexed citations
11.
Li, Yanfen, Matthias P. Fabritius, Stylianos Michalakis, et al.. (2021). The natural product vioprolide A exerts anti-inflammatory actions through inhibition of its cellular target NOP14 and downregulation of importin-dependent NF-ĸB p65 nuclear translocation. Biomedicine & Pharmacotherapy. 144. 112255–112255. 13 indexed citations
12.
13.
Bischoff, Iris, Christoph Schürmann, Jeremy Epah, et al.. (2019). Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. Journal of Molecular and Cellular Cardiology. 135. 97–108. 25 indexed citations
14.
Nieber, K, E Raskopf, O Kelber, et al.. (2019). Pharmaco-epidemiological research on herbal medicinal products in the paediatric population: data from the PhytoVIS study. European Journal of Pediatrics. 179(3). 507–512. 8 indexed citations
15.
Liebl, Johanna, Vladimı́r Kryštof, Libor Havlı́ček, et al.. (2013). Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors. PLoS ONE. 8(1). e54607–e54607. 23 indexed citations
16.
Uhl, Bernd, Jos Joore, Bettina Mayer, et al.. (2011). Roscovitine blocks leukocyte extravasation by inhibition of cyclin‐dependent kinases 5 and 9. British Journal of Pharmacology. 163(5). 1086–1098. 33 indexed citations
17.
Liebl, Johanna, György Vereb, Lili Takács, et al.. (2010). Cyclin-dependent Kinase 5 Regulates Endothelial Cell Migration and Angiogenesis. Journal of Biological Chemistry. 285(46). 35932–35943. 85 indexed citations
18.
Liebl, Johanna, et al.. (2008). Ginkgo biloba extract EGb® 761 exerts anti‐angiogenic effects via activation of tyrosine phosphatases. Journal of Cellular and Molecular Medicine. 13(8b). 2122–2130. 19 indexed citations
19.
Fürst, Robert, et al.. (2006). A Select Annotated Bibliography: Illegal Drug Research in Rural and Suburban Areas. Journal of Psychoactive Drugs. 38(2). 173–188. 3 indexed citations
20.
Kiemer, Alexandra K., Robert Fürst, & Angelika M. Vollmar. (2005). Vasoprotective Actions of the Atrial Natriuretic Peptide. PubMed. 3(1). 11–21. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofei Chen Breakdown of academic impact, for papers by Bikash Medhi Breakdown of academic impact, for papers by Zhihao Liu Breakdown of academic impact, for papers by Srinivasa Reddy Bonam Breakdown of academic impact, for papers by Hong Ding Breakdown of academic impact, for papers by Rongsheng Tong Breakdown of academic impact, for papers by Junko Watanabe Breakdown of academic impact, for papers by Fei Ye Breakdown of academic impact, for papers by Muhammad Afzal Breakdown of academic impact, for papers by Yun Jung Lee
Rankless by CCL
2026